Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor
Niel C. Hoglen, Long-Shiuh Chen, Craig D. Fisher, Brad P. Hirakawa, Todd Groessl and Patricia C. Contreras
Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 634-640; DOI: https://doi.org/10.1124/jpet.103.062034
Niel C. Hoglen
Long-Shiuh Chen
Craig D. Fisher
Brad P. Hirakawa
Todd Groessl
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 2
1 May 2004
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor
Niel C. Hoglen, Long-Shiuh Chen, Craig D. Fisher, Brad P. Hirakawa, Todd Groessl and Patricia C. Contreras
Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 634-640; DOI: https://doi.org/10.1124/jpet.103.062034
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor
Niel C. Hoglen, Long-Shiuh Chen, Craig D. Fisher, Brad P. Hirakawa, Todd Groessl and Patricia C. Contreras
Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 634-640; DOI: https://doi.org/10.1124/jpet.103.062034
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement